Nubilaria
Pre-clinicalFocuses on microbiome-based therapies for metabolic and gastrointestinal disorders.
Founded
2019
Focus
MicrobiomeMetabolic
About
Focuses on microbiome-based therapies for metabolic and gastrointestinal disorders.
Funding History
1Total raised: $1.8M
Seed$1.8MUndisclosedSep 15, 2022
Company Info
TypePrivate
Founded2019
LocationMilan, Italy
StagePre-clinical
Contact
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile